pdb	Hchain	Lchain	model	antigen_chain	antigen_type	antigen_het_name	antigen_name	short_header	date	compound	organism	heavy_species	light_species	antigen_species	authors	resolution	method	r_free	r_factor	scfv	engineered	heavy_subclass	light_subclass	light_ctype	affinity	delta_g	affinity_method	temperature	pmid
6mek	B	D	0	A	protein	NA	e2 glycoprotein	IMMUNE SYSTEM	09/06/18	Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design	HEPACIVIRUS C; HOMO SAPIENS	homo sapiens	homo sapiens	hepacivirus c	Flyak, A.I., Bjorkman, P.J.	3.1	X-RAY DIFFRACTION	0.290	0.223	False	True	IGHV1	IGKV1	Kappa	None	None	None	None	None
6mek	F	E	0	C	protein	NA	e2 glycoprotein	IMMUNE SYSTEM	09/06/18	Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design	HEPACIVIRUS C; HOMO SAPIENS	homo sapiens	homo sapiens	hepacivirus c	Flyak, A.I., Bjorkman, P.J.	3.1	X-RAY DIFFRACTION	0.290	0.223	False	True	IGHV1	IGLV1	Lambda	None	None	None	None	None
6mek	I	G	0	A	protein	NA	e2 glycoprotein	IMMUNE SYSTEM	09/06/18	Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design	HEPACIVIRUS C; HOMO SAPIENS	homo sapiens	homo sapiens	hepacivirus c	Flyak, A.I., Bjorkman, P.J.	3.1	X-RAY DIFFRACTION	0.290	0.223	False	True	IGHV1	IGLV1	Lambda	None	None	None	None	None
6mek	H	L	0	C	protein	NA	e2 glycoprotein	IMMUNE SYSTEM	09/06/18	Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design	HEPACIVIRUS C; HOMO SAPIENS	homo sapiens	homo sapiens	hepacivirus c	Flyak, A.I., Bjorkman, P.J.	3.1	X-RAY DIFFRACTION	0.290	0.223	False	True	IGHV1	IGKV1	Kappa	None	None	None	None	None